The Patent Finder
US

Salts of Potassium Atp Channel Openers and Uses Thereof

US 11,045,478 In force
OverviewFamilyAssignmentsSources & methods
Collateral for a security interest recorded Jun 26, 2026 (JPMorgan Chase Bank, N.A.).

Term ends Dec 20, 2026 · Low confidence

Filed Nov 11, 2019 as application 16/680,093 · Granted Jun 29, 2021
Base term, 20 years from filing
Today
20 years from filing
2006 2026
Clock starts
Dec 20, 2006
Term ends
Dec 20, 2026
Granted
Jun 29, 2021
base term fee events Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 10,085,998, US 7,799,777, US 9,381,202, to Dec 20, 2026. The term already ends on or before that date, so the cap shortened nothing.
1 of 1
Maintenance fees paid
One maintenance fee can end this term early, the one due 3.5 years from grant; the next one's grace period runs past the term end. This counts it if the record shows it paid.
9
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. 1 of 1 maintenance fees is paid so far. Confidence: Low. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Dec 20, 2006, when application 11/614,044, the earliest non-provisional in its chain, was filed (this one was filed Nov 11, 2019); a parent in its chain could not be resolved (the next row)Dec 20, 2026High confidence
Continuity chainA parent in the chain could not be resolveddated from this application's own claimMedium confidence
Patent term adjustmentNone on fileno changeHigh confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 10,085,998, US 7,799,777, US 9,381,202)resolves to Dec 20, 2026, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events1 of 1 maintenance fees paidIn forceHigh confidence
Further caveats on recordThe record names parents not resolved: 16110621, 15195826, 13846542, 12819155Low confidence overallLow confidence
Computed term endThe steps above, in orderDec 20, 2026Low confidence

This family

US 7,799,777In force
Mar 2029
Mar 2029
US 7,572,789In force
no later than Dec 2026
no later than Dec 2026
Application 12/819,155Abandoned
not computed
not computed
US 9,381,202In force
Jul 2027
Jul 2027
US 10,085,998In force
Dec 2026
Dec 2026
Application 16/110,621Abandoned
not computed
not computed
US 11,045,478this patent
Dec 2026
Dec 2026
US 11,786,536In force
Dec 2026
Dec 2026
8 of 9 applications in this family shown, earliest filings first. Every application listed has its file history here. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Jun 16, 2020
Reel 52956, frame 73
Cowen, Neil M.; Kashkin, Kenneth B.; Yamout, Khaled A.Essentialis, Inc.Assignment of Assignor's Interest
Dec 17, 2024
Reel 69613, frame 369
Soleno Therapeutics, Inc.; Essentialis, Inc.Oxford Finance LLC, as Collateral AgentSecurity Interest
Mar 12, 2025
Reel 70494, frame 42
Soleno Therapeutics, Inc.; Essentialis, Inc.Oxford Finance LLC, as Collateral AgentAmended and Restated Intellectual Property Security Agreement
Dec 3, 2025
Reel 73832, frame 312
Essentialis, Inc.Soleno Therapeutics, Inc.Assignment of Assignor's Interest
May 19, 2026
Reel 75778, frame 94
Oxford Finance LLC, as Collateral AgentSoleno Therapeutics, Inc.; Essentialis, Inc.Release of Security Interest (REEL 069613, Frame 0369)
May 19, 2026
Reel 75601, frame 687
Oxford Finance LLC, as Collateral AgentSoleno Therapeutics, Inc.; Essentialis, Inc.Release of Security Interest (REEL 070494, Frame 0042)
May 19, 2026
reel/frame not recorded
Oxford Finance LLC, as Collateral AgentSoleno Therapeutics, Inc.Release of Security Interest (REEL 070494, Frame 0042)
May 19, 2026
reel/frame not recorded
Oxford Finance LLC, as Collateral AgentEssentialis, Inc.Release of Security Interest (REEL 070494, Frame 0042)
May 19, 2026
reel/frame not recorded
Oxford Finance LLC, as Collateral AgentSoleno Therapeutics, Inc.Release of Security Interest (REEL 069613, Frame 0369)
May 19, 2026
reel/frame not recorded
Oxford Finance LLC, as Collateral AgentEssentialis, Inc.Release of Security Interest (REEL 069613, Frame 0369)
Jun 26, 2026
Reel 75106, frame 487
Soleno Therapeutics, Inc.JPMorgan Chase Bank, N.A., as Administrative AgentSecurity Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited